limiting the use of OTC cough and cold medicines in young children

January 2011

New evidence verifies the benefit of limiting the use of OTC cough and cold medicines in young children.

The infant versions are no longer marketed...and the remaining children's products are no longer labeled for children under age 4 or 6.

Now a new report suggests this is making a big difference.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote